ENOS is not activated by nebivolol in human failing myocardium

Life Sciences

Volumn 79, Issue 13, 2006, Pages 1234-1241

  Brixius, Klara ^a,b   Song, Qiaofeng ^a   Malick, Alock ^a   Boelck, Birgit ^a   Addicks, Klaus ^a   Bloch, Wilhelm ^b   Mehlhorn, Uwe ^a   Schwinger, Robert H G ^a,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^c Klinikum Weiden   (Germany)

Author keywords

BRL 37344; Carvedilol; eNOS; Heart failure; Metoprolol; Nebivolol

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARVEDILOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; METOPROLOL; NEBIVOLOL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ENZYME ACTIVATION; FEMALE; HEART ATRIUM; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; ORGAN DONOR; PHOSPHORYLATION; RAT; RAT STRAIN;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BENZOPYRANS; CELL SEPARATION; DENSITOMETRY; ETHANOLAMINES; HEART ATRIA; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; TISSUE FIXATION; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33747069122     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.03.030     Document Type: Article

References (15)

1. Bloch W., Mehlhorn U., Krahwinkel A., Reiner M., Dittrich M., Schmidt A., and Addicks K. Ischemia increases detectable endothelial nitric oxide synthase in rat and human myocardium. Nitric Oxide 5 (2001) 317-333
2. Bowman A.J., Chen C.P., and Ford G.A. Nitric oxide mediated venodilator effects of nebivolol. British Journal of Clinical Pharmacology 38 (1994) 199-204
3. Brixius K., Bloch W., Pott C., Napp A., Krahwinkel A., Ziskoven C., Koriller M., Mehlhorn U., Hescheler J., Fleischmann B., and Schwinger R.H.G. Mechanisms of beta 3-adrenoceptor-induced eNOS activation in right atrial and left ventricular human myocardium. British Journal of Pharmacology 143 (2004) 1014-1022
4. Cockcroft J.R., Chowienczyk P.J., Brett S.E., Chen C.P., Dupont A.G., Van Nueten L., Wooding S.J., and Ritter J.M. Nebivolol vasodilates human forearm vasculature: evidence for an l-arginine/NO-dependent mechanism. Journal of Pharmacology and Experimental Therapeutics 274 (1995) 1067-1071
5. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., and Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 (1999) 601-605
6. Dixon L.J., Morgan D.R., Hughes S.M., McGrath L.T., El-Sherbeeny N.A., Plumb R.D., Devine A., Leahey W., Johnston G.D., and McVeigh G.E. Functional consequences of endothelial nitric oxide synthase uncoupling in congestive cardiac failure. Circulation 107 (2003) 1725-1728
7. Fleming I., and Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. American Journal of Physiology 284 (2003) R1-R12
8. Fleming I., Fisslthaler B., Dimmeler S., Kemp B.E., and Busse R. Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circulation Research 88 (2001) E68-E75
9. Gao Y.S., Nagao T., Bond R.A., Janssens W.J., and Vanhoutte P.M. Nebivolol induces endothelium-dependent relaxations of canine coronary arteries. Journal of Cardiovascular Pharmacology 17 (1991) 964-969
10. Gauthier C., Tavernier G., Charpentier F., Langin D., and Le Marec H. Functional beta3-adrenoceptor in the human heart. Journal of Clinical Investigation 98 (1996) 556-562
11. Gauthier C., Leblais V., Kobzik L., Trochu J.N., Khandoudi N., Bril A., Balligand J.L., and Le Marec H. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. Journal of Clinical Investigation 102 (1998) 1377-1384
12. Gosgnach W., Boixel C., Nevo N., Poiraud T., and Michel J.B. Nebivolol induces calcium-independent signaling in endothelial cells by a possible beta-adrenergic pathway. Journal of Cardiovascular Pharmacology 38 (2001) 191-199
13. Kaumann A.J. (-)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptor. British Journal of Pharmacology 117 (1996) 93-98
14. Pott C., Brixius K., Bundkirchen A., Bolck B., Bloch W., Steinritz D., Mehlhorn U., and Schwinger R.H.G. The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium. British Journal of Pharmacology 138 (2003) 521-529
15. Wheeldon N.M., McDevitt D.G., McDevitt D.G., and Lipworth B.J. Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man. British Journal of Clinical Pharmacology 37 (1994) 363-369